Survivin and its splice variants are found to be associated with aggressive phenotypes of cancers [11] and may, if not prognostic, one day be considered like Her2 and hormone receptor to be predictive variables of breast cancer [3]. The gene discussed is ERBB2; the disease is breast carcinoma.